Professor Jim Chilcott delivered a presentation at the ISNS conference in Bratislava earlier this month. His presentation was titled: Screening for severe combined immunodeficiency: Using
probabilistic uncertainty analysis of economic models to assess the reliability of screening policy decisions. The slides are accessible below.
HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.
Showing posts with label presentation. Show all posts
Showing posts with label presentation. Show all posts
Wednesday, 31 October 2018
Friday, 23 September 2016
The economics of screening for ALD at a newborn screening
A bit of a delay on the HEDS news wire, but still very much news worthy is that our own Alice Bessey, Jim Chilcott and Jo Leavis gave an overview of the process to introduce X-ALD into new born screening to the UK which will support ALD Life’s application to the National Screening Committee.
The talk titled 'Cost-effectiveness of including X-ALD in the NHS newborn screening programme' was delivered earlier this year at the ALD Life Community Weekend. It aimed to prove that it is economically beneficial to the NHS to test newborn babies for ALD (Adrenoleukodystrophy) at birth. The talk can be viewed below.
The talk titled 'Cost-effectiveness of including X-ALD in the NHS newborn screening programme' was delivered earlier this year at the ALD Life Community Weekend. It aimed to prove that it is economically beneficial to the NHS to test newborn babies for ALD (Adrenoleukodystrophy) at birth. The talk can be viewed below.
Subscribe to:
Posts (Atom)